Leaflet CLAVUSIN 175.6mg / 175.6mg / ml cutaneous solution


Indicated for: warts; corns

Route of administration: cutaneous

Substance: salicylic acid + glacial acetic acid (keratolytic + caustic organic acid)

ATC: D11AFN1 (Dermatologicals | Other dermatological preparations | Wart and anti-corn preparations)

The combination of Acidum salycilicum + Acid acetic glacial is used in the treatment of dermatological conditions such as fungal infections, keratoses, or other skin conditions requiring exfoliation and disinfection. Salicylic acid acts as a keratolytic, helping to remove the stratum corneum of the skin, while glacial acetic acid has antimicrobial properties.

This combination is applied topically, usually as a solution, according to the doctor's instructions. It is effective in reducing symptoms and preventing secondary infections.

Side effects may include local irritation, burning sensation, or skin dryness. Long-term use or application on large areas should be avoided to prevent systemic side effects.

Consult your doctor to discuss the benefits and risks of using this combination. Follow the application instructions to ensure treatment effectiveness.

General data about CLAVUSIN 175.6mg / 175.6mg / ml

  • Substance: salicylic acid + glacial acetic acid
  • Date of last drug list: 01-07-2013
  • Commercial code: W00179001
  • Concentration: 175.6mg / 175.6mg / ml
  • Pharmaceutical form: cutaneous solution
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: MEDUMAN VISEU S.A. - ROMANIA
  • Holder: MEDUMAN VISEU S.A. - ROMANIA
  • Number: 12076/2019/01
  • Shelf life: 2 years-ambalat pt. comercializare;after the first opening of the bottle-30 days